Abstract
Objectives: In coronavirus disease 2019 (Covid-19), SARS-CoV-2 may use dipeptidyl peptidase 4 (DPP4) as an entry-point in different tissues expressing these receptors. DPP4 inhibitors (DPP4Is), also named gliptins, like sitagliptin, have anti-inflammatory and antioxidant effects, thereby lessen inflammatory and oxidative stress in diabetic Covid-19 patients. Therefore, the present study aimed to illustrate the potential beneficial effect of sitagliptin in managing Covid-19 in non-diabetic patients.
Methods: A total number of 89 patients with Covid-19 were recruited from a single center at the time of diagnosis. The recruited patients were assigned according to the standard therapy for Covid-19 and our interventional therapy into two groups; Group A: Covid-19 patients on the standard therapy (n=40) and Group B: Covid-19 patients on the standard therapy plus sitagliptin (n=49). The duration of this interventional study was 28 days according to the guideline in managing patients with Covid-19. Routine laboratory investigations, serological tests, Complete Blood Count (CBC), C-reactive Protein (CRP), D-dimer, lactate dehydrogenase (LDH), and serum ferritin were measured to observed Covid-19 severity and complications. Lung Computed Tomography (CT) and clinical scores were evaluated.
Results: The present study illustrated that sitagliptin as an add-on to standard therapy improved clinical outcomes, radiological scores, and inflammatory biomarkers than standard therapy alone in non-diabetic patients with Covid-19 (P<0.01).
Conclusion: Sitagliptin as an add-on to standard therapy in managing non-diabetic Covid-19 patients may have a robust beneficial effect by modulating inflammatory cytokines with subsequent good clinical outcomes.
Keywords: Covid-19, sitagliptin, non-diabetic patients, DPP4, angiotensin-converting enzyme 2, inflammatory cytokines.
Graphical Abstract
[http://dx.doi.org/10.3389/fmed.2021.644295] [PMID: 33718411]
[http://dx.doi.org/10.1016/j.jmii.2020.04.015] [PMID: 32414646]
[http://dx.doi.org/10.1016/j.bcp.2021.114431] [PMID: 33515531]
[http://dx.doi.org/10.3389/fcvm.2021.642181]
[http://dx.doi.org/10.1016/j.pupt.2021.102008] [PMID: 33727066]
[http://dx.doi.org/10.3389/fnut.2021.649128] [PMID: 33816542]
[http://dx.doi.org/10.1007/s13300-018-0488-z] [PMID: 30117055]
[http://dx.doi.org/10.4103/japtr.JAPTR_18_20] [PMID: 33102198]
[http://dx.doi.org/10.1177/2040622319875305] [PMID: 31555430]
[http://dx.doi.org/10.4103/bbrj.bbrj_7_20]
[http://dx.doi.org/10.1016/j.ejmech.2018.03.041] [PMID: 29609120]
[http://dx.doi.org/10.3892/etm.2021.9649] [PMID: 33574913]
[http://dx.doi.org/10.1007/s00210-017-1367-2] [PMID: 28382499]
[http://dx.doi.org/10.1016/j.mehy.2020.110111] [PMID: 32721805]
[http://dx.doi.org/10.2337/dc20-1521] [PMID: 32994187]
[http://dx.doi.org/10.1093/cid/ciaa478] [PMID: 32338708]
[http://dx.doi.org/10.1007/s00330-020-07033-y] [PMID: 32623505]
[http://dx.doi.org/10.4103/japtr.JAPTR_65_19] [PMID: 31742116]
[http://dx.doi.org/10.4103/japtr.JAPTR_298_18] [PMID: 30338238]
[http://dx.doi.org/10.1038/s41598-020-75651-z] [PMID: 33188225]
[http://dx.doi.org/10.2337/dci20-0062] [PMID: 33033068]
[http://dx.doi.org/10.2478/acph-2021-0013] [PMID: 33151168]
[http://dx.doi.org/10.1111/1753-0407.13052] [PMID: 32394639]
[http://dx.doi.org/10.1080/14740338.2018.1444027] [PMID: 29468916]
[http://dx.doi.org/10.3389/fcvm.2021.644095] [PMID: 34124187]
[http://dx.doi.org/10.1016/j.celrep.2018.07.045] [PMID: 30110630]
[http://dx.doi.org/10.1002/dmrr.3330] [PMID: 32336007]
[http://dx.doi.org/10.1152/ajpendo.00323.2019] [PMID: 31891536]
[http://dx.doi.org/10.3390/jcm9082511] [PMID: 32759719]
[http://dx.doi.org/10.1038/s41401-019-0272-2] [PMID: 31316183]
[http://dx.doi.org/10.1016/j.isci.2020.101160] [PMID: 32405622]
[http://dx.doi.org/10.3389/fphar.2021.642822] [PMID: 33967777]
[http://dx.doi.org/10.1002/dmrr.2723] [PMID: 26417956]
[http://dx.doi.org/10.1016/j.diabres.2020.108125] [PMID: 32224164]
[http://dx.doi.org/10.1210/endrev/bnaa011] [PMID: 32294179]
[http://dx.doi.org/10.1016/j.pharmthera.2020.107503] [PMID: 32061923]
[http://dx.doi.org/10.1002/med.21513] [PMID: 29806214]
[http://dx.doi.org/10.1159/000490688] [PMID: 29913457]
[http://dx.doi.org/10.1007/s10557-018-6778-x] [PMID: 29508169]
[http://dx.doi.org/10.1016/j.arcmed.2020.04.019] [PMID: 32402576]
[http://dx.doi.org/10.1016/j.mehy.2020.110102] [PMID: 32721799]
[http://dx.doi.org/10.1007/s10930-020-09935-8] [PMID: 33106987]
[http://dx.doi.org/10.2147/DMSO.S132537] [PMID: 28652790]
[http://dx.doi.org/10.22541/au.159493007.74229845]
[http://dx.doi.org/10.3390/ph14010044] [PMID: 33430081]
[http://dx.doi.org/10.3389/fendo.2019.00080] [PMID: 30828317]
[http://dx.doi.org/10.1038/s41366-020-00689-y] [PMID: 32958905]
[http://dx.doi.org/10.1080/08958378.2019.1597220] [PMID: 31068039]
[http://dx.doi.org/10.1016/j.ejphar.2019.172638] [PMID: 31491403]
[http://dx.doi.org/10.1007/s11739-020-02389-x] [PMID: 32592113]
[http://dx.doi.org/10.1016/j.cmet.2020.04.021] [PMID: 32369736]
[http://dx.doi.org/10.1111/dom.14329] [PMID: 33502076]
[http://dx.doi.org/10.1007/s13300-014-0084-9] [PMID: 25256818]
[http://dx.doi.org/10.1016/j.scitotenv.2020.142579] [PMID: 33601667]